Prostate CancerGTSPNCT07792109
Implementation Of A Telesurgery Program At A Referral Center For Robotic Surgery
A study testing Robot-Assisted Telesurgery in people with Prostate Cancer and Colorectal Cancer, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 3 sites in Italy.
Trial summary
This prospective, single-center pilot cohort study aims to evaluate the feasibility and safety of implementing a robotic telesurgery program in a tertiary academic referral center. Adult patients scheduled for elective robotic procedures, like radical prostatectomy or colectomy . Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Prostate Cancer, Colorectal Cancer
- What is being tested?
- Robot-Assisted Telesurgery
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 25 participants
- Where
- 3 sitesItaly
- Study dates
- 20 Aug 2026to 30 May 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥18 years.
- American Society of Anesthesiologists (ASA) physical status I-II.
- No significant comorbidities according to the Charlson Comorbidity Index.
- No history of major abdominal surgery.
- Scheduled for elective robot-assisted surgery.
- Able to understand the study procedures and provide written informed consent.
Who cannot join
- Severe comorbidities that may interfere with study participation or surgical safety.
- Severe bleeding or coagulation disorders, or ongoing treatments that significantly affect coagulation.
- Inability to understand the study procedures or provide informed consent.
- Unwillingness or inability to comply with the study protocol.
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Italy3 sites
Unita Operativa Complessa - Urologia - Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, RM, 00168
Maria Chiara MC sighinolfi, md, phD, +393291329216, mariachiara.sighinolfi@policlinicogemelli.it
Maria Chiara Sighinolfi
Unita Operativa Complessa di Ginecologia Oncologica e UOC Carcinoma Ovarico, IRCCS Gemelli
Rome, Roma, 00168
Anna Fagotti
Anna Fagotti
Unita Oprativa Complessa Chirurgia Generale - IRCCS Fondazione Policlinico Gemelli , Roma
Rome, Roma, 00168
Sergio Alfieri
Sergio Alfieri
About this study
Official title: Implementation Of A Telesurgery Program At A Referral Center For Robotic Surgery: Feasibility And Safety Evaluation - Gemelli TeleSurgery Program (GTSP)
This prospective, single-center pilot cohort study aims to evaluate the feasibility and safety of implementing a robotic telesurgery program in a tertiary academic referral center. Adult patients scheduled for elective robotic procedures, like radical prostatectomy or colectomy . Surgical procedures will be performed using the Toumai robotic surgical system. During predefined operative steps, a remote console surgeon located at Gemelli Isola Hospital will perform selected surgical tasks, while the primary console surgeon, the patient, and the entire operating room team remain at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The local surgeon can immediately resume control of the robotic system whenever required. First objective is to assess the feasibility and safety of telesurgery by evaluating the rate of conversion from remote to local robotic surgery. Other objectives include assessment of network performance, technical reliability, perioperative outcomes, and user and patient satisfaction.
Read the detailed description
Telesurgery is an emerging application of robotic-assisted surgery that enables surgeons to perform selected operative tasks remotely through advanced robotic systems and secure telecommunication technologies. Recent advances in robotic platforms, high-speed network infrastructures, and low-latency connectivity have renewed interest in the clinical implementation of telesurgery. Nevertheless, its adoption in routine clinical practice remains limited because further evidence regarding technical feasibility, safety, organizational requirements, and reproducibility is needed.
Consecutive adult patients eligible for robot-assisted procedures will be enrolled over a three-month recruitment period.
All procedures will be performed at Fondazione Policlinico Universitario Agostino Gemelli IRCCS using the Toumai robotic surgical platform. The patient, bedside surgical team, and primary console surgeon will remain at the Gemelli Hospital throughout the procedure. During predefined surgical phases, a second console surgeon located at Gemelli Isola Hospital will remotely perform selected operative steps. A dedicated network infrastructure with redundant dark-fiber connections, encrypted communication, and predefined latency thresholds has been implemented to ensure secure and reliable data transmission. Whenever considered necessary because of technical issues or surgical judgment, the local console surgeon can immediately resume direct control of the robotic system according to predefined safety protocols.
The primary endpoint is the conversion rate from remote telesurgical control to local robotic surgery during the telesurgical phases of the operation. Secondary endpoints include assessment of technical performance, network latency and reliability, intraoperative and postoperative outcomes, device-related malfunctions, and user and patient satisfaction. The study is intended to generate clinical and organizational evidence supporting the safe implementation of robotic telesurgery in routine surgical practice.
- Conditions
- Prostate Cancer, Colorectal Cancer
- Being tested
- Robot-Assisted Telesurgery
- Keywords
- Robotic Surgery, Remote Surgery, Prostatectomy, Colectomy, Prostate Cancer, Colorectal Cancer, Feasibility
- Medical subject headings
- Prostatic Neoplasms, Colorectal Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Robot-Assisted TelesurgeryDevice
Robot-assisted telesurgery performed using the Toumai robotic surgical system. Patients undergo robotic surgery at Fondazione Policlinico Gemelli IRCCS. The surgical procedure is initiated and completed by the local surgical team, while one or more predefined surgical steps are performed remotely by a second console surgeon located at Isola Tiberina Hospital. At any time during the procedure, the local console surgeon can immediately resume control of the robotic system if required.
| Study group | Role | What they receive |
|---|---|---|
| Patients Undergoing Robotic Surgery With Remote Surgical Support | Experimental | Patients undergoing robot-assisted telesurgery, with the operating surgeon located at a remote hospital site while the patient undergoes the procedure at the referral center. Receives: Device: Robot-Assisted Telesurgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Conversion Rate from Remote to Local Robotic Surgery (%)
Rate (%) of conversion from remote robotic surgery to completion of the procedure by the local console surgeon without further remote surgical involvement (due to unintended/urgent/emergency issues)
Measured: Intraoperatively
Secondary outcomes (5)
Rate of Intraoperative Adverse Events
Occurrence and severity of intraoperative adverse events graded according to the Satava grading system and ICARUS classification.
Measured: Intraoperatively
Postoperative Complications
Postoperative complications graded according to the Clavien-Dindo classification.
Measured: Up to 30 post-operative days
Network Latency (msec)
Mean network latency recorded during the entire surgical procedure and during each surgical step.
Measured: Intraoperatively
Rate of Technical Malfunctions
Number and type of technical malfunctions, including alarms, collisions, and deviations from the planned surgical strategy.
Measured: Intraoperatively
Length of Hospital Stay (day)
Length of postoperative hospital stay.
Measured: Time (days) up to hospital discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Aug 2026
- Study start20 Aug 2026 (estimated)
- Primary completion30 Nov 2026 (estimated)
- Study completion30 May 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (14)Papers the sponsor has linked to this study.
- Other trials for Prostate CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Single-arm prospective interventional study evaluating the feasibility and safety of a telesurgery program during robot-assisted surgical procedures performed at a tertiary referral center.
- Masking
- None (open label)
- Enrolment
- 25 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rocco Bernardo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Investigators
- Bernardo Rocco, Principal investigator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07792109
- Sponsor's protocol ID
- 7727
- Acronym
- GTSP
- Status last verified
- Aug 2026
- First submitted
- 5 Aug 2026
- Last updated
- 28 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Reitano G, Tumminello A, Ghaffar U, Saggionetto G, Taverna A, Mangiacavallo F, Ahmed ME, Basourakos SP, Carletti F, Minardi D, Iafrate M, Morlacco A, Betto G, Karnes RJ, Moro FD, Zattoni F, Novara G. Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis. Eur Urol Open Sci. 2025 Mar 3;74:44-70. doi: 10.1016/j.euros.2025.02.003. eCollection 2025 Apr.
PubMed 40115596Pokhrel G, Zheng H, Tao J, Cui J, Fan Y, Li Z, Dong B, Yu S, Zhang X. Assessing the Feasibility and Safety of the Toumai(R) Robotic System in Urologic Surgery: Initial Experience. J Endourol. 2024 Jun;38(6):552-558. doi: 10.1089/end.2024.0028.
PubMed 38468506Pokhrel G, Zheng H, Tao J, Fan Y, Liu Y, Dong B, Yu S, Zhang X. Evaluation of the Toumai robotic system in partial nephrectomy and key system features. Sci Rep. 2025 Apr 16;15(1):13046. doi: 10.1038/s41598-025-97124-x.
PubMed 40240465Rocco B, Patel V, Covas Moschovas M, Gaia G, Sighinolfi MC. Pre-clinical evaluation of telesurgery with the Toumai microport: the standpoint from multiplatform users. Minerva Urol Nephrol. 2024 Dec;76(6):671-673. doi: 10.23736/S2724-6051.24.06091-9. No abstract available.
PubMed 39831852Patel V, Collins JW, Marescaux J, Dohler M, Saikali S, Dasgupta P, Reddy S, Gamal A, Patel E, Rogers T, Siddiqui A, Breda A, Mottrie A, Hassan A, Hung A, Secord A, Rocco B, Pugh C, Sundaram C, Sighinolfi MC, Ellison EC, Davila EP, Wilson E, Balkhy H, Kaouk J, Liang C, Kavoussi LR, Roche M, Martino M, Anvari M, Sylla P, Coelho RF, Thomas R, Clayman R, Leveillee R, Estape R, Goldberg R, Madder R, Horgan S, Magnuson JS, Nathan S, Ross S, Costello A, Xu Z, Chauhan S, Redan J, Satava R, Miles B, Sachdeva AK, Moschovas MC. International multispecialty consensus statement and expert opinion of best practices in telesurgery. J Robot Surg. 2025 Apr 1;19(1):135. doi: 10.1007/s11701-025-02298-1. No abstract available.
PubMed 40167848Wu S, Wu N, Wang Y, Jing R, Wu Y, Yi S. 5G remote robotic-assisted transcervical thyroidectomy: the first case report in the world. BMC Surg. 2025 Apr 25;25(1):182. doi: 10.1186/s12893-025-02927-4.
PubMed 40281540Ferreira SV, Sugai MH, Nascimento GC, Souza AC Netto, Cabrini GC, Rodrigues FM, D'Avila CLR, Souza GF, Zerati RV, Zerati M Filho. Feasibility and Initial Outcomes of Telesurgery in Urology: a Systematic Review of the Literature. Int Braz J Urol. 2025 May-Jun;51(3):e20240494. doi: 10.1590/S1677-5538.IBJU.2024.0494.
PubMed 40079922Tian Y, Lv H, Jumai A, Tuerhong T, Zhuang L, Huang J, Li J, Lu P, Tao G, Yamauchi Y, Flores RM, Teng H, Chen T, Luo Q. Ultra-remote robot-assisted right upper lobectomy between the Shanghai and Kashi Prefectures: a case report. J Thorac Dis. 2024 Dec 31;16(12):8823-8830. doi: 10.21037/jtd-24-1605. Epub 2024 Dec 27.
PubMed 39831214Aldousari S, Almarzouq A, Hassan A, Shahin A, Bubishate S, Bahbahani B. The era of telesurgery: insights from ultra-long-distance Asia to Middle East human telesurgery robotic assisted radical prostatectomy. J Robot Surg. 2025 Mar 11;19(1):108. doi: 10.1007/s11701-025-02274-9.
PubMed 40064737Rocco B, Moschovas MC, Saikali S, Gaia G, Patel V, Sighinolfi MC. Insights from telesurgery expert conference on recent clinical experience and current status of remote surgery. J Robot Surg. 2024 Jun 4;18(1):240. doi: 10.1007/s11701-024-01984-w.
PubMed 38833111Moschovas MC, Dohler M, Patel V. Telesurgery: Challenges, Ethical Considerations, and Opportunities in the Robotic Surgery Era. Eur Urol Focus. 2025 Jan;11(1):40-42. doi: 10.1016/j.euf.2025.02.016. Epub 2025 Mar 3.
PubMed 40037973Moschovas MC, Saikali S, Dohler M, Patel E, Rogers T, Gamal A, Marquinez J, Patel V. Advancing Telesurgery Connectivity Between North and South America: the first Remote Surgery Conducted Between Orlando and Sao Paulo in Animal Models. Int Braz J Urol. 2025 Jan-Feb;51(1):e20240601. doi: 10.1590/S1677-5538.IBJU.2024.0601. No abstract available.
PubMed 39556854Moschovas MC, Palmer K, Barani G, Corder C, Carnegie P, Dhanji T, Patel E, Paxi A, Figueiredo JC, Luis B, Matos A, Dohler M, Patel V. Expanding access to high-quality surgical care in Africa: a landmark achievement in telesurgery. J Robot Surg. 2025 Mar 24;19(1):124. doi: 10.1007/s11701-025-02292-7.
PubMed 40128381Moschovas MC, Saikali S, Rogers T, Dohler M, Mcdonald M, Patel E, Marquinez J, Gamal A, Magnuson J, Patel V. Exploring the Teleproctoring Potential of Telesurgery: The First Remote Procedures Performed Simultaneously Between Orlando and Shanghai. Int Braz J Urol. 2025 Jul-Aug;51(4):e20250083. doi: 10.1590/S1677-5538.IBJU.2025.0083.
PubMed 40112129
Study at a glance
From the registry record, last updated by the sponsor on 28 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Implementation Of A Telesurgery Program At A Referral Center For Robotic Surgery: Feasibility And Safety Evaluation - Gemelli TeleSurgery Program (GTSP)
- ClinicalTrials.gov ID
- NCT07792109
- Acronym / sponsor ID
- GTSP / 7727
- Conditions
- Prostate Cancer, Colorectal Cancer
- Keywords
- Robotic Surgery, Remote Surgery, Prostatectomy, Colectomy, Prostate Cancer, Colorectal Cancer, Feasibility
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 25 participants (estimated)
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSUniversity, hospital or other
- Study start
- 20 Aug 2026 (estimated)
- Primary completion
- 30 Nov 2026 (estimated)
- Study completion
- 30 May 2027 (estimated)
- First posted
- 28 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This prospective, single-center pilot cohort study aims to evaluate the feasibility and safety of implementing a robotic telesurgery program in a tertiary academic referral center. Adult patients scheduled for elective robotic procedures, like radical prostatectomy or colectomy . Surgical procedures will be performed using the Toumai robotic surgical system. During predefined operative steps, a remote console surgeon located at Gemelli Isola Hospital will perform selected surgical tasks, while the primary console surgeon, the patient, and the entire operating room team remain at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The local surgeon can immediately resume control of the robotic system whenever required. First objective is to assess the feasibility and safety of telesurgery by evaluating the rate of conversion from remote to local robotic surgery. Other objectives include assessment of network performance, technical reliability, perioperative outcomes, and user and patient satisfaction.
Detailed description
Telesurgery is an emerging application of robotic-assisted surgery that enables surgeons to perform selected operative tasks remotely through advanced robotic systems and secure telecommunication technologies. Recent advances in robotic platforms, high-speed network infrastructures, and low-latency connectivity have renewed interest in the clinical implementation of telesurgery. Nevertheless, its adoption in routine clinical practice remains limited because further evidence regarding technical feasibility, safety, organizational requirements, and reproducibility is needed.
Consecutive adult patients eligible for robot-assisted procedures will be enrolled over a three-month recruitment period.
All procedures will be performed at Fondazione Policlinico Universitario Agostino Gemelli IRCCS using the Toumai robotic surgical platform. The patient, bedside surgical team, and primary console surgeon will remain at the Gemelli Hospital throughout the procedure. During predefined surgical phases, a second console surgeon located at Gemelli Isola Hospital will remotely perform selected operative steps. A dedicated network infrastructure with redundant dark-fiber connections, encrypted communication, and predefined latency thresholds has been implemented to ensure secure and reliable data transmission. Whenever considered necessary because of technical issues or surgical judgment, the local console surgeon can immediately resume direct control of the robotic system according to predefined safety protocols.
The primary endpoint is the conversion rate from remote telesurgical control to local robotic surgery during the telesurgical phases of the operation. Secondary endpoints include assessment of technical performance, network latency and reliability, intraoperative and postoperative outcomes, device-related malfunctions, and user and patient satisfaction. The study is intended to generate clinical and organizational evidence supporting the safe implementation of robotic telesurgery in routine surgical practice.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Single-arm prospective interventional study evaluating the feasibility and safety of a telesurgery program during robot-assisted surgical procedures performed at a tertiary referral center.
| Arm | Type | Receives |
|---|---|---|
| Patients Undergoing Robotic Surgery With Remote Surgical Support | Experimental | Device: Robot-Assisted TelesurgeryPatients undergoing robot-assisted telesurgery, with the operating surgeon located at a remote hospital site while the patient undergoes the procedure at the referral center. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Age ≥18 years.
- American Society of Anesthesiologists (ASA) physical status I-II.
- No significant comorbidities according to the Charlson Comorbidity Index.
- No history of major abdominal surgery.
- Scheduled for elective robot-assisted surgery.
Key exclusion criteria (4 listed)
- Severe comorbidities that may interfere with study participation or surgical safety.
- Severe bleeding or coagulation disorders, or ongoing treatments that significantly affect coagulation.
- Inability to understand the study procedures or provide informed consent.
- Unwillingness or inability to comply with the study protocol.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Robot-Assisted TelesurgeryRobot-assisted telesurgery performed using the Toumai robotic surgical system. Patients undergo robotic surgery at Fondazione Policlinico Gemelli IRCCS. The surgical procedure is initiated and completed by the local surgical team, while one or more predefined surgical steps are performed remotely by a second console surgeon located at Isola Tiberina Hospital. At any time during the procedure, the local console surgeon can immediately resume control of the robotic system if required. | Device | Patients Undergoing Robotic Surgery With Remote Surgical Support |
Primary outcome
Conversion Rate from Remote to Local Robotic Surgery (%)
Time frame: Intraoperatively
Rate (%) of conversion from remote robotic surgery to completion of the procedure by the local console surgeon without further remote surgical involvement (due to unintended/urgent/emergency issues)
5 secondary outcomes
Rate of Intraoperative Adverse Events
Time frame: Intraoperatively
Postoperative Complications
Time frame: Up to 30 post-operative days
Network Latency (msec)
Time frame: Intraoperatively
Rate of Technical Malfunctions
Time frame: Intraoperatively
Length of Hospital Stay (day)
Time frame: Time (days) up to hospital discharge
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Aug 2026.
- Background: PubMed 40115596Reitano G, Tumminello A, Ghaffar U, Saggionetto G, Taverna A, Mangiacavallo F, Ahmed ME, Basourakos SP, Carletti F, Minardi D, Iafrate M, Morlacco A, Betto G, Karnes RJ, Moro FD, Zattoni F, Novara G. Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis. Eur Urol Open Sci. 2025 Mar 3;74:44-70. doi: 10.1016/j.euros.2025.02.003. eCollection 2025 Apr.
- Background: PubMed 38468506Pokhrel G, Zheng H, Tao J, Cui J, Fan Y, Li Z, Dong B, Yu S, Zhang X. Assessing the Feasibility and Safety of the Toumai(R) Robotic System in Urologic Surgery: Initial Experience. J Endourol. 2024 Jun;38(6):552-558. doi: 10.1089/end.2024.0028.
- Background: PubMed 40240465Pokhrel G, Zheng H, Tao J, Fan Y, Liu Y, Dong B, Yu S, Zhang X. Evaluation of the Toumai robotic system in partial nephrectomy and key system features. Sci Rep. 2025 Apr 16;15(1):13046. doi: 10.1038/s41598-025-97124-x.
- Background: PubMed 39831852Rocco B, Patel V, Covas Moschovas M, Gaia G, Sighinolfi MC. Pre-clinical evaluation of telesurgery with the Toumai microport: the standpoint from multiplatform users. Minerva Urol Nephrol. 2024 Dec;76(6):671-673. doi: 10.23736/S2724-6051.24.06091-9. No abstract available.
- Background: PubMed 40167848Patel V, Collins JW, Marescaux J, Dohler M, Saikali S, Dasgupta P, Reddy S, Gamal A, Patel E, Rogers T, Siddiqui A, Breda A, Mottrie A, Hassan A, Hung A, Secord A, Rocco B, Pugh C, Sundaram C, Sighinolfi MC, Ellison EC, Davila EP, Wilson E, Balkhy H, Kaouk J, Liang C, Kavoussi LR, Roche M, Martino M, Anvari M, Sylla P, Coelho RF, Thomas R, Clayman R, Leveillee R, Estape R, Goldberg R, Madder R, Horgan S, Magnuson JS, Nathan S, Ross S, Costello A, Xu Z, Chauhan S, Redan J, Satava R, Miles B, Sachdeva AK, Moschovas MC. International multispecialty consensus statement and expert opinion of best practices in telesurgery. J Robot Surg. 2025 Apr 1;19(1):135. doi: 10.1007/s11701-025-02298-1. No abstract available.
- Background: PubMed 40281540Wu S, Wu N, Wang Y, Jing R, Wu Y, Yi S. 5G remote robotic-assisted transcervical thyroidectomy: the first case report in the world. BMC Surg. 2025 Apr 25;25(1):182. doi: 10.1186/s12893-025-02927-4.
- Background: PubMed 40079922Ferreira SV, Sugai MH, Nascimento GC, Souza AC Netto, Cabrini GC, Rodrigues FM, D'Avila CLR, Souza GF, Zerati RV, Zerati M Filho. Feasibility and Initial Outcomes of Telesurgery in Urology: a Systematic Review of the Literature. Int Braz J Urol. 2025 May-Jun;51(3):e20240494. doi: 10.1590/S1677-5538.IBJU.2024.0494.
- Background: PubMed 39831214Tian Y, Lv H, Jumai A, Tuerhong T, Zhuang L, Huang J, Li J, Lu P, Tao G, Yamauchi Y, Flores RM, Teng H, Chen T, Luo Q. Ultra-remote robot-assisted right upper lobectomy between the Shanghai and Kashi Prefectures: a case report. J Thorac Dis. 2024 Dec 31;16(12):8823-8830. doi: 10.21037/jtd-24-1605. Epub 2024 Dec 27.
- Background: PubMed 40064737Aldousari S, Almarzouq A, Hassan A, Shahin A, Bubishate S, Bahbahani B. The era of telesurgery: insights from ultra-long-distance Asia to Middle East human telesurgery robotic assisted radical prostatectomy. J Robot Surg. 2025 Mar 11;19(1):108. doi: 10.1007/s11701-025-02274-9.
- Background: PubMed 38833111Rocco B, Moschovas MC, Saikali S, Gaia G, Patel V, Sighinolfi MC. Insights from telesurgery expert conference on recent clinical experience and current status of remote surgery. J Robot Surg. 2024 Jun 4;18(1):240. doi: 10.1007/s11701-024-01984-w.
- Background: PubMed 40037973Moschovas MC, Dohler M, Patel V. Telesurgery: Challenges, Ethical Considerations, and Opportunities in the Robotic Surgery Era. Eur Urol Focus. 2025 Jan;11(1):40-42. doi: 10.1016/j.euf.2025.02.016. Epub 2025 Mar 3.
- Background: PubMed 39556854Moschovas MC, Saikali S, Dohler M, Patel E, Rogers T, Gamal A, Marquinez J, Patel V. Advancing Telesurgery Connectivity Between North and South America: the first Remote Surgery Conducted Between Orlando and Sao Paulo in Animal Models. Int Braz J Urol. 2025 Jan-Feb;51(1):e20240601. doi: 10.1590/S1677-5538.IBJU.2024.0601. No abstract available.
- Individual participant dataSharing planned: No
Related trials for Prostate Cancer
RecruitingPhase 1/2
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Active, not recruiting
Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer
Malignant Prostate Neoplasm
Enrolling by invitation
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
Adenocarcinoma, Prostate Neoplasms
RecruitingObservational study
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Prostatic Neoplasms, Prostate Cancer
RecruitingPhase 1
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Breast Neoplasms, Colorectal Neoplasms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Bernardo Rocco principal investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Robot-Assisted Telesurgery in people with Prostate Cancer and Colorectal Cancer, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 3 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 28 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact BERNARDO B ROCCO, MD (+393358306522, bernardomariacesare.rocco@policlinicogemelli.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Conversion Rate from Remote to Local Robotic Surgery (%) (time frame: Intraoperatively). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07792109, which also lists 14 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2026.